IL1B and multiple sclerosis: Interestingly, NFKF blocked the production of IL-1β and IL-6 in spleen leukocytes possibly via CB2 receptor activation, while in the inguinal lymph nodes only IL-1ß was significantly reduced, suggesting a role for these peptides in the treatment of multiple sclerosis (Heimann et al., 2020).